References
<A NAME="RG07005ST-1">1</A>
Jones C.
Carbohydrates in Europe
1998,
21:
10
<A NAME="RG07005ST-2A">2a</A>
Lindberg AA.
Vaccine
1999,
17:
S28
<A NAME="RG07005ST-2B">2b</A>
Morley SL.
Pollard AJ.
Vaccine
2002,
20:
666
<A NAME="RG07005ST-3A">3a</A>
Gold R.
Lepow ML.
Goldschneider I.
Gotschlich EC.
J. Infect. Dis.
1977,
136:
S31
<A NAME="RG07005ST-3B">3b</A>
Reingold AL.
Broome CV.
Hightower AW.
Ajello GW.
Bolan GA.
Adamsbaum C.
Jones EE.
Phillips C.
Tiendrebeogo H.
Yada A.
Lancet
1985,
2:
114
<A NAME="RG07005ST-4A">4a</A>
Pozsgay V. In
Advances in Carbohydrate Chemistry and Biochemistry
Vol. 56:
Tipson RS.
Horton D.
Academic Press;
New York:
2000.
p.153
<A NAME="RG07005ST-4B">4b</A>
Ravenscroft N.
Jones C.
Curr. Opin. Drug Discovery Dev.
2000,
3:
222
<A NAME="RG07005ST-5A">5a</A>
Bishop CT.
Jennings HJ. In
The Polysaccharides
Vol. 16:
Aspinall GO.
Academic Press;
New York:
1982.
p.292
<A NAME="RG07005ST-5B">5b</A>
Jennings HJ. In
Advances in Carbohydrate Chemistry and Biochemistry
Vol. 41:
Tipson RS.
Horton D.
Academic Press;
New York:
1983.
p.155
<A NAME="RG07005ST-5C">5c</A>
Arndt B.
Porro M. In
Immunobiology of Proteins and Peptides VI
Atassi MZ.
Plenum Press;
New York:
1991.
p.129
<A NAME="RG07005ST-6A">6a</A>
Schneerson R.
Barrera O.
Sutton A.
Robbins JB.
J. Exp. Med.
1980,
152:
361
<A NAME="RG07005ST-6B">6b</A>
Robbins JB.
Schneerson R.
Anderson P.
Smith DH.
J. Am. Med. Assoc.
1996,
276:
1181
<A NAME="RG07005ST-7A">7a</A>
Pozsgay V.
J. Org. Chem.
1998,
63:
5983
<A NAME="RG07005ST-7B">7b</A>
Pozsgay V.
Chu C.
Pannell L.
Wolfe J.
Robbins JB.
Schneerson R.
Proc. Natl. Acad. Sci. U.S.A.
1999,
96:
5194
<A NAME="RG07005ST-8">8</A>
Verez-Bencomo V.
Fernandez-Santana V.
Hardy E.
Toledo ME.
Rodriguez MC.
Heynngnezz L.
Rodriguez A.
Baly A.
Herrera L.
Izquierdo M.
Villar A.
Valdés Y.
Cosme K.
Deler ML.
Montane M.
Garcia E.
Ramos A.
Aguilar A.
Medina E.
Toraño G.
Sosa I.
Hernandez I.
Martinez R.
Muzachio A.
Carmenates A.
Costa L.
Cardoso F.
Campa C.
Diaz M.
Roy R.
Science
2004,
305:
522
<A NAME="RG07005ST-9A">9a</A>
Bundle DR.
Smith ICP.
Jennings HJ.
J. Biol. Chem.
1974,
249:
83
<A NAME="RG07005ST-9B">9b</A>
Lemercinier X.
Jones C.
Biologicals
2000,
28:
175
<A NAME="RG07005ST-10">10</A>
Costantino P,
Berti F,
Norelli F, and
Bartoloni A. inventors; Int. Appl. WO 03/080678 A1.
; Chem. Abstr. 2003, 139, 275732
Reviews:
<A NAME="RG07005ST-11A">11a</A>
Engel R.
Chem. Rev.
1977,
77:
349
<A NAME="RG07005ST-11B">11b</A>
Nicotra F. In
Carbohydrate Mimics
Chapleur Y.
Wiley-VCH;
Weinheim:
1998.
p.67
<A NAME="RG07005ST-11C">11c</A>
Compain P.
Martin OR.
Bioorg. Med. Chem.
2001,
9:
3077
See also:
<A NAME="RG07005ST-11D">11d</A>
Vargas LA.
Miao LX.
Rosenthal AF.
Biochim. Biophys. Acta
1984,
796:
123
<A NAME="RG07005ST-11E">11e</A>
Blackburn GM.
Thatcher GR.
Taylor GE.
Prescott M.
McLennan AG.
Nucleic Acids Res.
1987,
15:
6991
<A NAME="RG07005ST-11F">11f</A>
Biller SA.
Forster C.
Gordon EM.
Harrity T.
Scott WA.
Ciosek CP.
J. Med. Chem.
1988,
31:
1869
<A NAME="RG07005ST-11G">11g</A>
Bartlett PA.
Hanson JE.
Giannousis PP.
J. Org. Chem.
1990,
55:
6268
<A NAME="RG07005ST-11H">11h</A>
Morgan BP.
Scholtz JM.
Ballinger MD.
Zipkin ID.
Bartlett PA.
J. Am. Chem. Soc.
1991,
113:
297
<A NAME="RG07005ST-11I">11i</A>
Orsini F.
Di Teodoro E.
Tetrahedron: Asymmetry
2002,
13:
1307
<A NAME="RG07005ST-11L">11l</A>
Wen X.
Hultin PG.
Tetrahedron Lett.
2004,
45:
1773
<A NAME="RG07005ST-12A">12a</A>
Cipolla L.
Lay L.
Nicotra F.
Panza L.
Russo G.
J. Chem. Soc., Chem. Commun.
1995,
1993
<A NAME="RG07005ST-12B">12b</A>
Casero F.
Cipolla L.
Lay L.
Nicotra F.
Panza L.
Russo G.
J. Org. Chem.
1996,
61:
3428
<A NAME="RG07005ST-13">13</A>
Draghetti V.
Poletti L.
Prosperi D.
Lay L.
J. Carbohydr. Chem.
2001,
20:
813
<A NAME="RG07005ST-14A">14a</A>
Babirad SA.
Wang Y.
Kishi Y.
J. Org. Chem.
1987,
52:
1370
<A NAME="RG07005ST-14B">14b</A>
Kobertz WR.
Bertozzi CR.
Bednarski MD.
Tetrahedron Lett.
1992,
33:
737
<A NAME="RG07005ST-14C">14c</A>
Bertozzi CR.
Bednarski MD.
Tetrahedron Lett.
1992,
33:
3109
<A NAME="RG07005ST-15">15</A>
All new compounds gave satisfactory analytical and spectroscopic data.
<A NAME="RG07005ST-16">16</A>
Staudinger H.
Meyer J.
Helv. Chim. Acta
1919,
2:
635
<A NAME="RG07005ST-17">17</A>
Garegg PJ.
Samuelsson B.
J. Chem. Soc., Perkin Trans. 1
1980,
2866
<A NAME="RG07005ST-18">18</A>
Wang MF.
Crilley MML.
Golding BT.
McInally T.
Robinson DH.
Tinker A.
J. Chem. Soc., Chem. Commun.
1991,
667
<A NAME="RG07005ST-19">19</A>
Spectroscopic and analytical data of compound 11: [α]D
25 +20.7 (c 1.0, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 7.37-7.19 (m, 15 H, Ph), 5.87 (d, 1 H, J = 9.3 Hz, NH), 4.65, 4.56 (each d, each 1 H, J
gem = 11.7 Hz, CH
2
Ph), 4.55, 4.51 (each d, each 1 H, J
gem = 11.9 Hz, CH
2
Ph), 4.46, 4.41 (each d, each 1 H, J
gem = 11.5 Hz, CH
2
Ph), 4.36 (dt, 1 H, J
2,1 = 3.5 Hz = J
2,3, H-2), 4.16 (m, 1 H, H-1), 4.00 (dd, 1 H, J
5,6a = 5.1 = J
5,4, J
5,6b = 9.7 Hz, H-5), 3.82 (dd, 1 H, J
6a,6b = 10.0, H-6a), 3.78-3.69 (m, 3 H, H-3, H-4, H-6b), 3.74 (d, 3 H, J
Me,P = 11.3 Hz, OMe), 3.71 (d, 3 H, J
Me,P = 11.3 Hz, OMe), 2.13 (dt, 1 H, J
7a,1 = 9.3 Hz, J
7a,7b = 15.7 Hz = J
7a,P, H-7a), 2.04 (dt, 1 H, J
7b,1 = 4.0 Hz, J
7b,P = 15.7 Hz, H-7b), 1.87 (s, 3 H, COCH
3). 13C NMR (100.6 MHz, CDCl3): δ = 170.37 (CO), 138.39, 138.27, 137.74 (C ipso), 129.19-128.15 (Ph), 76.49 (C-3), 74.06 (C-5), 73.81, 73.35, 72.31 (3 CH
2
Ph), 72.31 (C-4), 68.79 (C-1), 68.69 (C-6), 53.26 (d, J
OMe,P = 5.9 Hz, OMe), 52.60 (d, J
OMe,P = 5.9 Hz, OMe), 45.28 (d, J
2,P = 14.8 Hz, C-2), 28.06 (d, J
7,P = 142.0 Hz, C-7), 23.71 (COCH3). 31P NMR (162 MHz, CDCl3): δ = 32.48. HRMS (MALDI): m/z calcd for C32H40NO8PNa: 620.2389 [M + Na+]; found: 620.2386; m/z calcd for C32H40NO8PK: 636.2129 [M + K+]; found: 636.2132.
<A NAME="RG07005ST-20">20</A>
Müller B.
Martin TJ.
Schaub C.
Schmidt RR.
Tetrahedron Lett.
1998,
39:
509
<A NAME="RG07005ST-21">21</A>
Yang G.
Ding X.
Kong F.
Tetrahedron Lett.
1997,
38:
6725
<A NAME="RG07005ST-22">22</A>
Malachowski WP.
Coward JK.
J. Org. Chem.
1994,
59:
7616
<A NAME="RG07005ST-23A">23a</A>
Norbeck DW.
Kramer JB.
Lartey PA.
J. Org. Chem.
1987,
52:
2174
<A NAME="RG07005ST-23B">23b</A>
Campbell DA.
J. Org. Chem.
1992,
57:
6331
<A NAME="RG07005ST-23C">23c</A>
Malachowski WP.
Coward JK.
J. Org. Chem.
1994,
59:
7625
<A NAME="RG07005ST-23D">23d</A>
Pungente MD.
Weiler L.
Org. Lett.
2001,
3:
643
<A NAME="RG07005ST-23E">23e</A>
Borodkin VS.
Milne FC.
Ferguson MAJ.
Nikolaev AV.
Tetrahedron Lett.
2002,
43:
7821
<A NAME="RG07005ST-24">24</A>
A fraction containing a single phosphorous diastereoisomer of 16 was isolated during column chromatography and fully characterized: [α]D
25 +8.1 (c 0.25, CHCl3). 1H NMR (500 MHz, CDCl3): δ = 8.25 (br s, 1 H, NH), 7.46-7.25 (m, 25 H, Ph), 5.76 (br d, 1 H, NH), 5.28 (br
s, 1 H, NH), 5.11 (s, 2 H, CH
2
Ph Z), 4.95, 4.60 (each d, each 1 H, J
gem = 10.7 Hz, CH
2
Ph), 4.89 (1 H, overlapping signal, H-2), 4.89, 4.51 (each d, each 1 H, J
gem = 10.9 Hz, CH
2
Ph), 4.66, 4.59 (each d, each 1 H, J
gem = 11.8 Hz, CH
2
Ph), 4.49, 4.42 (each d, each 1 H, J
gem = 11.9 Hz, CH
2
Ph), 4.45 (br s, 1 H, H-1), 4.37-4.29 (m, 2 H, H-2′, H-6a), 4.22 (br dd, 1 H, J
6a,6b = 12.0 Hz, H-6b), 4.14 (m, 1 H, H-1′), 4.04 (dd, 1 H, J
3
′
,4
′ = 9.7 Hz, J
3
′
,2
′ = 5.4 Hz, H-3′), 3.92-3.77 (m, 6 H, H-4, H-7a, H-4′, H-5′, H-6′a, H-6′), 3.75 (d,
3 H, J
Me,P = 10.9 Hz, OMe), 3.69 (dd, 1 H, J
3,4 = 8.3 Hz, J
3,2 = 3.7 Hz, H-3), 3.58 (m, 1 H, H-7b), 3.38 (br d, 1 H, J
5,4 = 9.5 Hz, H-5), 3.27 (m, 2 H, H-9a, H-9b), 2.23-2.06 (m, 2 H, H-7′a, H-7′b), 1.84
(br s, 6 H, COCH
3
), 1.78 (m, 2 H, H-8a, H-8b). 13C NMR (125.7 MHz, CDCl3): δ = 171.62 (CO), 169.82 (CO), 156.52 (CO Z), 138.21 (2 × C), 137.92, 137.61, 137.11
(C ipso), 128.73-127.80 (Ph), 99.57 (C-1), 79.88 (C-3), 75.92, 73.01, 71.81 (C-4, C-4′,
C-5′), 75.24, 73.35, 72.80, 71.06 (4 CH2Ph), 74.51 (C-5), 73.75 (C-3′), 68.24 (C-1′), 68.21 (C-6′), 67.49 (C-7), 66.79 (d,
J
6,P = 38.5 Hz, C-6), 66.54 (CH2Ph Z), 53.87 (d, J
OMe,P = 6.8 Hz, OMe), 49.94 (C-2), 48.68 (d, J
2
′
,P = 12.8, C-2′), 38.46 (C-9), 30.81 (C-7′), 29.64 (C-8), 23.98 (COCH3), 23.31 (COCH3). 31P NMR (202.5 MHz, CDCl3): δ = 29.71. HRMS (ESI): m/z calcd for C57H70N3O15PNa: 1090.4436 [M + Na+]; found: 1090.4410.
<A NAME="RG07005ST-25">25</A>
Spectroscopic and analytical data of compound 17: [α]D
25 -40.5 (c 1.0, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 7.78 (br s, 1 H, NH), 7.34-7.20 (m, 30 H, Ph), 5.92 (d, 1 H, J = 8.9 Hz, NH), 5.14 (s, 2 H, CH
2
Ph Z), 4.98, 4.62 (each d, each 1 H, J
gem = 10.8 Hz, CH
2
Ph), 4.98, 4.52 (each d, each 1 H, J
gem = 10.8 Hz, CH
2
Ph), 4.80 (br dd, 1 H, H-2), 4.74, 4.50 (each d, each 1 H, J
gem = 11.3 Hz, CH
2
Ph), 4.63-4.52 (m, 3 H, H-1, H-2′, H-6a), 4.54, 4.47 (each d, each 1 H, J
gem = 11.4 Hz, CH
2
Ph), 4.42, 4.32 (each d, each 1 H, J
gem = 12.1 Hz, CH
2
Ph), 4.26 (m, 1 H, H-1′), 4.18 (br dd, 1 H, J
6a,6b = 11.4 Hz, H-6b), 3.98-3.87 (m, 3 H, H-4, H-5′, H-7a), 3.81-3.79 (m, 3 H, H-3′, H-4′,
H-6′a), 3.73 (dd, 1 H, J
6
′
b,6
′
a = 9.7 Hz, J
6
′
b,5 = 2.9 Hz, H-6′b), 3.68 (dd, 1 H, J
3,2 = 3.5 Hz, J
3,4 = 9.4 Hz, H-3), 3.53 (br s, 1 H, H-7b), 3.39 (d, 1 H, J
5,4 = 9.5 Hz, H-5), 3,34 (m, 1 H, H-9a), 3.10 (m, 1 H, H-9b), 2.27 (dt, 1 H, J
7
′
a,1
′ = 10.2 Hz, J
7
′
a,7
′
b = 16.8 Hz = J
7
′
a,P, H-7′a), 2.07 (1 H, overlapping signal, H-7′b), 2.07 (s, 3 H, COCH
3
), 1.85 (s, 3 H, COCH
3
), 1.73 (m, 2 H, H-8a, H-8b). 13C NMR (100.6 MHz, CDCl3): δ = 171.79 (CO), 169.88 (CO), 159.46 (CO Z), 138.34 (2 × C), 138.11, 138.02, 137.87 (2, C ipso), 128.58-127.66 (Ph), 97.27 (C-1), 80.12 (C-3), 76.82 (C-3′), 75.38, 73.86,
73.30, 71.37, 70.74 (5 CH2Ph), 73.86 (C-5), 73.10 (C-4′), 72.74 (C-4, C-5′), 71.05 (C-1′), 68.40 (C-6′), 67.62
(CH2Ph Z), 65.13 (d, J
6,P = 37.8 Hz, C-6), 62.09 (C-7), 49.47 (C-2), 48.90 (d, J
2
′
,P = 15.3, C-2′), 37.40 (C-9), 28.76 (d, J
7
′
,P = 147.6 Hz, C-7′), 27.21 (C-8), 23.42 (COCH3), 22.94 (COCH3). 31P NMR (202.5 MHz, CDCl3): δ = 24.83. HRMS (MALDI): m/z calcd for C63H73N3O15PNa: 1166.4677 [M + H+]; found: 1167.4669; m/z calcd for C63H73N3O15PNa2: 1188.4575 [M + H + Na+]; found: 1189.4552.
<A NAME="RG07005ST-26">26</A>
Spectroscopic and analytical data of compound 1: [α]D
25 -17.8 (c 1.0, H2O). 1H NMR (400 MHz, D2O): δ = 4.94 (d, 1 H, J
1,2 = 1.7 Hz, H-1), 4.69 (1 H, overlapped by HDO signal, H-2), 4.51 (br dd, 1 H, H-2′),
4.38-4.23 (m, 3 H, H-1′, H-6a, H-6b), 4.17-4.08 (m, 2 H, H-3′, H-7a), 4.02-3.93 (m,
4 H, H-3, H-7b, H-6′a, H-6′b), 3.81-3.73 (m, 3 H, H-4, H-4′, H-5′), 3.66 (m, 1 H,
H-5), 3.26 (br t, 2 H, J = 7.5 Hz, H-9a, H-9b), 2.40-2.27 (m, 2 H, H-7′a, H-7′), 2.22 (s, 3 H, COCH
3
), 2.20 (s, 3 H, COCH
3
), 2.11 (m, 2 H, H-8a, H-8b). 13C NMR (100.6 MHz, D2O): δ = 175.73 (CO), 174.60 (CO), 99.73 (C-1), 75.63 (C-5), 74.44, 67.70, 66.90 (C-4,
C-4′, C-5′), 72.84 (C-1′), 71.86 (C-3), 69.57 (C-3′), 67.97 (C-7), 63.38 (C-6), 60.77
(C-6′), 53.27 (C-2), 53.05 (d, J
2
′
,P = 9.7 Hz, C-2′), 38.02 (C-9), 27.80 (d, J
7
′
,P = 134.6 Hz, C-7′), 26.85 (C-8), 22.31 (2 COCH3). 31P NMR (162 MHz, D2O): δ = 22.95. HRMS (ESI): m/z calcd for C20H38N3O13PNa: 582.2034 [M + H+]; found: 582.2035; m/z calcd for C20H37N3O13PNa2: 604.1853 [M + Na+]; found: 604.1857.